Tenax Therapeutics (TENX) Revenue & Revenue Breakdown
Tenax Therapeutics Revenue Highlights
Tenax Therapeutics Revenue by Period
Tenax Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | -100.00% |
| 2015-04-30 | $49.29K | -82.93% |
| 2014-04-30 | $288.73K | -76.60% |
| 2013-04-30 | $1.23M | 197.33% |
| 2012-04-30 | $415.03K | 28.75% |
| 2011-04-30 | $322.35K | 100.00% |
| 2010-04-30 | - | 100.00% |
| 2009-04-30 | - | 100.00% |
| 2008-04-30 | - | -100.00% |
| 2007-04-30 | $-24.13K | -5.86% |
| 2006-04-30 | $-25.63K | 100.00% |
| 2005-04-30 | - | 100.00% |
| 2004-04-30 | - | 100.00% |
| 2003-04-30 | - | 100.00% |
| 2002-04-30 | - | -100.00% |
| 2001-04-30 | $1.00 | - |
| 2000-04-30 | $1.00 | -100.00% |
| 1999-04-30 | $100.00K | 100.00% |
| 1998-04-30 | - | 100.00% |
| 1997-04-30 | - | 100.00% |
| 1996-04-30 | - | - |
Tenax Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tenax Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $5.79K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $21.22K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-10-31 | - | 100.00% |
| 2015-07-31 | - | -100.00% |
| 2015-04-30 | $49.29K | 100.00% |
| 2015-01-31 | - | 100.00% |
| 2014-10-31 | - | 100.00% |
| 2014-07-31 | - | -100.00% |
| 2014-04-30 | $-5.92K | -114.01% |
| 2014-01-31 | $42.27K | -28.42% |
| 2013-10-31 | $59.06K | -69.45% |
| 2013-07-31 | $193.31K | -7.11% |
| 2013-04-30 | $208.10K | -7.06% |
| 2013-01-31 | $223.92K | -57.27% |
| 2012-10-31 | $524.01K | 88.49% |
| 2012-07-31 | $278.01K | 180.46% |
| 2012-04-30 | $99.12K | -34.26% |
| 2012-01-31 | $150.77K | 42.70% |
| 2011-10-31 | $105.66K | 77.65% |
| 2011-07-31 | $59.48K | -73.78% |
| 2011-04-30 | $226.81K | 331.50% |
| 2011-01-31 | $52.56K | 45.67% |
| 2010-10-31 | $36.08K | 100.00% |
| 2010-07-31 | - | 100.00% |
| 2010-04-30 | - | 100.00% |
| 2010-01-31 | - | 100.00% |
| 2009-10-31 | - | 100.00% |
| 2009-07-31 | - | 100.00% |
| 2009-04-30 | - | 100.00% |
| 2009-01-31 | - | 100.00% |
| 2008-10-31 | - | 100.00% |
| 2008-07-31 | - | 100.00% |
| 2008-04-30 | - | - |
Tenax Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tenax Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ENSC | Ensysce Biosciences | $2.23M | - |
| BXRX | Baudax Bio | $1.27M | - |
| UNCY | Unicycive Therapeutics | $675.00K | - |
| ADTX | Aditxt | $645.18K | $44.28K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
| CYTO | Altamira Therapeutics | - | $52.73K |
| PXMD | PaxMedica | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| DRMA | Dermata Therapeutics | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| ALLR | Allarity Therapeutics | - | - |
| TENX | Tenax Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| BWV | Onconetix | - | - |
| WINT | Windtree Therapeutics | - | - |
TENX Revenue FAQ
What is Tenax Therapeutics’s yearly revenue?
Tenax Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TENX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Tenax Therapeutics’s quarterly revenue?
Tenax Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $5.79K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). TENX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Tenax Therapeutics’s revenue growth rate?
Tenax Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.